Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.36 USD | +0.71% | +7.36% | -13.87% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 68.47M | Sales 2025 * | 59.1M | Capitalization | 2.52B |
---|---|---|---|---|---|
Net income 2024 * | -490M | Net income 2025 * | -533M | EV / Sales 2024 * | 28.6 x |
Net cash position 2024 * | 567M | Net cash position 2025 * | 509M | EV / Sales 2025 * | 34.1 x |
P/E ratio 2024 * |
-5.08
x | P/E ratio 2025 * |
-4.91
x | Employees | 526 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.8% |
Latest transcript on Intellia Therapeutics, Inc.
1 day | -0.19% | ||
1 week | +5.27% | ||
Current month | +22.29% | ||
1 month | +19.99% | ||
3 months | -5.66% | ||
6 months | +0.58% | ||
Current year | -14.17% |
Managers | Title | Age | Since |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 18-10-28 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 19-01-23 |
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Frank Verwiel
CHM | Chairman | 62 | 17-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.15% | 2 M€ | -25.75% | ||
4.87% | 1 M€ | 0.00% | - | |
4.17% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 26.26 | +0.34% | 341 445 |
24-05-16 | 26.17 | -0.19% | 1,236,486 |
24-05-15 | 26.22 | +1.90% | 1,381,069 |
24-05-14 | 25.73 | +1.22% | 1,198,167 |
24-05-13 | 25.42 | +3.92% | 1,697,948 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.17% | 2.52B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.24% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- NTLA Stock